
Stay apprised of our latest & greatest developments via a new, dedicated, life sciences handle, @RevvityLifeSci
Lawrence, MA
Joined January 2009
- Tweets1.4K
- Following285
- Followers353
- Likes348
Nexcelom retweeted
What is image cytometry? What are its advantages? What are the key applications? Find out in our new blog! ms.spr.ly/60159J5d1
Nexcelom retweeted
Register today for a webinar and live Q&A on August 24 with Dr. Paul Weingarten and Dr. William Rice. ms.spr.ly/60199Jjex
Nexcelom retweeted
Introducing Revvity: a visionary partner developing technologies and solutions across disease pathways to help solve the world's greatest health challenges. Read more here. ms.spr.ly/6015gVGAR
Introducing Revvity
Nexcelom retweeted
The Cellaca® PLX Image Cytometry System by Nexcelom Bioscience has been nominated for Best New Drug Discovery & Development Product of 2022! If you are a scientist in the field of #drugdiscovery and development, cast your vote: https://xitter.gq/t.co/fbJtnMeE14
@PerkinElmer @Nexcelom
Nexcelom retweeted
NEW APPLICATION NOTE - We use Cellometer® K2 @Nexcelom @PerkinElmer to optimize #sequencing costs and avoid issues from poor sample quality. Quality In=Quality Out, Are you seeing all your cells? https://xitter.gq/t.co/S7wXzxmAxl #data #quality #cryopreservation #singlecell
Nexcelom retweeted
Curious to learn more about applying modern technology platforms to develop therapeutic products and monitor immune response? In this now on-demand webinar, hear from the experts. Find it here: https://xitter.gq/t.co/Nxyok2fDj5
@Nexcelom
Nexcelom retweeted
In this upcoming webinar with @Nexcelom, get insight on the application of gene editing tools to generate a new CHOSOURCE™ ADCC+ cell line from Horizon’s Tulshi Patel and more. Register now: https://xitter.gq/t.co/5tUqKF43eK
Nexcelom retweeted
See our ViaCheck #CellViability #standards used to establish reference focal plane for #reproducible #TrypanBlue #viability measurements
#Bioprocessing #Biotherapeutics @NIST @Nexcelom #CHIBioprocessingSummit Article: https://xitter.gq/t.co/FZGT6VyyPf ViaCheck: https://xitter.gq/t.co/jyWw5XTC9n
Our protocol is online! star-protocols.cell.com/prot…
@STARProtocols @10xGenomics @Nexcelom
Multi-omics profiling of single nuclei from frozen archived postmortem... sciencedirect.com/science/ar…
Nexcelom retweeted
Some exciting news from our partner @Nexcelom with the Cellaca MX High-throughput Automated Cell Counter.
Interested in a demo? Simply click the link below to request a virtual or in-person demo for your lab:
hubs.li/Q01bsXK50
Nexcelom retweeted
Thank you #ELRIG and @Nexcelom for this wonderful opportunity. Fantastic talks at Advances in Cell Based Screening 2022, ELRIG, to accelerate use of 3D models in drug screening👏 @BuffaFrancesca @OxfordOncology
Nexcelom is proud to be a Platinum Sponsor at #ELRIG Cell Based Screening 2022 , May 10-12 in Gothenburg.
Visit our booth & on May 10th from 10:25 to 10:55. Anjali Arora will present "Breast cancer cellular models of hypoxia for high-throughput drug screening"
Nexcelom retweeted
A lot to unpack from #AACR22 but it's all good. Actually great. It was a well run event, very efficient. Props to @AACR! Hats off to the @PKILifeScience @HZDiscovery @BioLegend @PerkinElmer & @Nexcelom Teams. The hard work doesn't start, it continues. I miss you already #NOLA!
Nexcelom retweeted
Our cancer discovery & applied genomics portfolio spanning across our @PKILifeScience, @PerkinElmer_AG, @HZDiscovery, @Nexcelom, & @BioLegend experts help ID more target drug candidates faster & better, paving the way for tailored therapies... #TeamPKI https://xitter.gq/t.co/jPULIB7gPi
Nexcelom retweeted
Our cancer discovery & applied genomics portfolio spanning across our @PKILifeScience, @PerkinElmer_AG, @HZDiscovery, @Nexcelom, & @BioLegend experts help ID more target drug candidates faster & better, paving the way for tailored therapies unique to each cancer patient. #AACR22.
Nexcelom retweeted
We are off and running in the Big Easy for #AACR22. Before asking Zoltar where to go & what to do, be sure to learn about the technology, the trends & the innovations behind today’s cancer research and where it's going with PerkinElmer. cc @PerkinElmer @AACR @BioLegend @Nexcelom
Nexcelom retweeted
#AACR22 Fun fact: Our cancer discovery portfolio spanning across our @PKILifeScience, @PerkinElmer_AG, @HZDiscovery, @Nexcelom, & @BioLegend experts helps ID more target drug candidates faster & better, paving the way for tailored therapies unique to each cancer patient
Nexcelom retweeted
Explore new ways to guarantee consistency in your cell counting across all methods and instruments during BPI West thanks to our partners @Nexcelom
Nexcelom retweeted
Don’t miss our upcoming discussion with @Nexcelom on enabling novel technologies to effectively develop T and NK cell-based therapeutic products featuring our own Vanda Lopes, PhD. Register now: https://xitter.gq/t.co/5M7IsrVZBS
Nexcelom retweeted
It’s the final yeast counting day of 2021 over here and your friendly wayward molecular biologist is feeling in the holiday spirit. @Nexcelom #x2cellometer





































